MMC(TMZ)-TOC has high binding affinity and selectivity for somatostatin receptor subtype-2 (SSTR2). MMC(TMZ)-TOC targets delivery of TMZ to SSTR2-positive tumor cells. MMC(TMZ)-TOC can be used for the research of cancer[1].
Molecular Weight:
1611.80
Formula:
C72H98N20O19S2
Target:
Somatostatin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted